BridgeMD
New treatment option for Obsessive-Compulsive Disorder
Official title Digital Mindfulness-Based Therapy for Obsessive-Compulsive Disorder
ClinicalTrials.gov ID: NCT07701616
What this study is testing
What is Routine Pharmacological Treatment?
Routine Pharmacological Treatment is an investigational medicine, given as an once-weekly, being studied as a potential treatment for obsessive-compulsive disorder.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This randomized controlled trial aims to evaluate the effects of digital mindfulness-based therapy in people with obsessive-compulsive disorder and to explore its possible psychological and neurophysiological mechanisms. A total of 150 participants with a primary diagnosis of obsessive-compulsive disorder will be randomly assigned in a 1:1:1 ratio to one of three groups: digital mindfulness-based therapy, routine pharmacological treatment, or digital mindfulness-based therapy combined with routine pharmacological treatment.
- Time commitment: about 6 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 65
You may be able to join if
- A primary diagnosis of obsessive-compulsive disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).
- Aged 12 to 65 years.
- Primary school education or above and able to understand the study procedures and complete the required assessments.
- Willing and able to provide written informed consent. For participants under 18 years of age, written informed consent will also be obtained from a...
- Participants who are already receiving psychotropic medication must have maintained a stable medication regimen for at least 4 weeks before...
You likely can't join if
- Current or lifetime diagnosis of schizophrenia spectrum disorder, bipolar disorder, substance use disorder, or personality disorder.
- Severe physical illness or central nervous system disease that may interfere with participation in the study.
- Severe suicidal ideation or suicidal behavior within the past month.
- Pregnancy, planned pregnancy, or breastfeeding.
- Concurrent participation in another psychotherapy program or clinical trial.
- Mindfulness practice within the past month.
See the full eligibility criteria
- A primary diagnosis of obsessive-compulsive disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).
- Aged 12 to 65 years.
- Primary school education or above and able to understand the study procedures and complete the required assessments.
- Willing and able to provide written informed consent. For participants under 18 years of age, written informed consent will also be obtained from a parent or legal guardian.
- Participants who are already receiving psychotropic medication must have maintained a stable medication regimen for at least 4 weeks before enrollment. Any clinically necessary medication changes during the study will...
- Current or lifetime diagnosis of schizophrenia spectrum disorder, bipolar disorder, substance use disorder, or personality disorder.
- Severe physical illness or central nervous system disease that may interfere with participation in the study.
- Severe suicidal ideation or suicidal behavior within the past month.
- Pregnancy, planned pregnancy, or breastfeeding.
- Concurrent participation in another psychotherapy program or clinical trial.
- Mindfulness practice within the past month.
- Inability to understand or comply with the study procedures.
The study team makes the final eligibility decision.
Where it's taking place
- Changsha, Hunan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 6 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Changsha, Hunan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.